MACK
T. Rowe Price Associates’s Merrimack Pharmaceuticals, Inc. MACK Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-10,500
| Closed | -$67K | – | 3036 |
|
|
2021
Q2 | $67K | Hold |
10,500
| – | – | ﹤0.01% | 2873 |
|
|
2021
Q1 | $66K | Buy |
+10,500
| New | +$66K | ﹤0.01% | 2806 |
|
|
2017
Q3 | – | Sell |
-43,640
| Closed | -$54K | – | 2599 |
|
|
2017
Q2 | $54K | Buy |
43,640
+40
| +0.1% | +$49 | ﹤0.01% | 2523 |
|
|
2017
Q1 | $134K | Hold |
43,600
| – | – | ﹤0.01% | 2459 |
|
|
2016
Q4 | $178K | Hold |
43,600
| – | – | ﹤0.01% | 2402 |
|
|
2016
Q3 | $277K | Hold |
43,600
| – | – | ﹤0.01% | 2250 |
|
|
2016
Q2 | $235K | Buy |
43,600
+11,800
| +37% | +$63.6K | ﹤0.01% | 2264 |
|
|
2016
Q1 | $266K | Hold |
31,800
| – | – | ﹤0.01% | 2202 |
|
|
2015
Q4 | $251K | Sell |
31,800
-21,600
| -40% | -$170K | ﹤0.01% | 2220 |
|
|
2015
Q3 | $454K | Buy |
53,400
+10,100
| +23% | +$85.9K | ﹤0.01% | 1997 |
|
|
2015
Q2 | $535K | Buy |
43,300
+14,800
| +52% | +$183K | ﹤0.01% | 1967 |
|
|
2015
Q1 | $339K | Sell |
28,500
-12,300
| -30% | -$146K | ﹤0.01% | 2134 |
|
|
2014
Q4 | $461K | Buy |
40,800
+15,100
| +59% | +$171K | ﹤0.01% | 1989 |
|
|
2014
Q3 | $226K | Hold |
25,700
| – | – | ﹤0.01% | 2279 |
|
|
2014
Q2 | $187K | Buy |
25,700
+10,700
| +71% | +$77.9K | ﹤0.01% | 2368 |
|
|
2014
Q1 | $76K | Hold |
15,000
| – | – | ﹤0.01% | 2453 |
|
|
2013
Q4 | $80K | Sell |
15,000
-1,332,097
| -99% | -$7.1M | ﹤0.01% | 2422 |
|
|
2013
Q3 | $5.12M | Buy |
+1,347,097
| New | +$5.12M | ﹤0.01% | 1419 |
|